U. Berglund et T. Lindahl, ENHANCED ONSET OF PLATELET INHIBITION WITH A LOADING DOSE OF TICLOPIDINE IN ASA-TREATED STABLE CORONARY PATIENTS, International journal of cardiology, 64(2), 1998, pp. 215-217
Antiplatelet therapy reduces the rate of complications of coronary ang
ioplasty. Ticlopidine, in addition to acetyl salicytic acid (ASA), imp
roves the results after coronary stenting, but early complications sti
ll occur. Ticlopidine given in the standard way has a slow onset of ac
tion. Eighteen ASA-treated stable coronary patients were randomized to
standard ticlopidine treatment (250 mg twice daily) or to a loading d
ose of 1500 mg followed by 250 mg twice daily. After one day, standard
treatment had a very modest antiplatelet effect, as assessed by ADP-i
nduced platelet fibrinogen binding, whereas the loading dose resulted
in a considerably better platelet inhibition; relative inhibition, 5.6
-10.6 vs. 24.9-35.3% (p<0.005) with final ADP concentrations 3 and 0.6
mu M, respectively. It is possible that a loading dose of ticlopidine
, given the day before the procedure, might reduce the complications r
elated to angioplasty and stenting. (C) 1998 Elsevier Science Ireland
Ltd.